Matrix remodeling is crucial for neovascularization, however its utilization to control this process in synthetic biomaterials has been limited. Here, we utilized hyaluronic acid (HA) hydrogels to spatially control cellular remodeling during vascular network formation. Specifically, we exploited a secondary radical polymerization to alter the ability of cells to degrade the hydrogel and utilized it to create spatial patterning using light initiation. We first demonstrated the ability of the hydrogel to either support or inhibit in vitro vasculogenesis of endothelial colony-forming cells (ECFCs) or angiogenesis from ex ovo chorioallantoic membranes. We showed that vascular tube branching and sprouting, which required matrix metalloproteinases (MMPs)-dependent remodeling, could be achieved in hydrogels formed by primary addition-crosslinking only. Although ECFCs expressed higher levels of MMPs in the hydrogels with the secondary radical crosslinking, the generated kinetic chains disabled cell-mediated remodeling and therefore vascular formation was arrested at the vacuole and lumen stage. We then patterned hydrogels to have regions that either permitted or inhibited cell-mediated degradation during in vitro vasculogenesis or angiogenesis. Our ability to control degradation cues that regulate vascular tube formation is important for the study of vascular biology and the application of synthetic biomaterials in tissue regeneration.
Introduction
The vascular system is formed through both vasculogenesis, the de novo formation of blood vessels, and angiogenesis, the sprouting of vessels from a pre-existing vascular tube [1, 2] . Bone marrowderived endothelial colony-forming cells (ECFCs) participate in vascular repair and regeneration through postnatal vasculogenesis and angiogenesis [3] . In response to stimuli, ECFCs migrate, differentiate, degrade the extracellular matrix (ECM), and undergo tubulogenesis. These processes are spatiotemporally regulated by biochemical and biophysical cues of the ECM [4] . Much of our understanding of these molecular regulations has been elucidated by the development of well-defined in vitro vasculogenesis and angiogenesis models using natural ECM, such as matrigel, collagen, and fibrin gels [5e8]. Many angiogenic factors have been identified to stimulate and "permit" angiogenesis [9, 10] , while other small molecules have been found to "inhibit" angiogenesis and have been developed as drugs to inhibit tumor growth [11] . In addition, different ECM components have also been shown to "permit" or "inhibit" angiogenesis [12, 13] .
Spatial control over vascular formation is essential for the generation of well-organized vascular networks toward application in tissue regeneration [2,14e16] ; however, such control is difficult to achieve in natural matrices due to their inherent chemical and physical properties, which limit their manipulability. Synthetic biomaterials have been suggested as a xeno-free and more clinically relevant alternative for therapeutic vascularization [17, 18] and vascular network formation [19, 20] . Due to their versatility, these synthetic biomaterials can be designed with the incorporation of biochemical cues, such as soluble factors, cell adhesion, and degradation sites to provide instructive microenvironments to recapitulate complex stages of vascular morphogenesis [21] . Furthermore, recent study exploited spatial control over cell adhesion to guide the formation of well-organized vasculatures in PEG-based hydrogels [22] . Here we sought to explore cell-mediated degradation to provide spatial control over vascular morphogenesis. Although ECM remodeling has been shown to occur during vasculogenesis and angiogenesis [23, 24] , its utilization in controlling these processes in synthetic biomaterials has been limited [25] . Using our basic understanding of polymer chemistry and vascular cell-mediated degradation, we can manipulate synthetic biomaterials to provide controlled remodeling cues, which are either "permissive" or "inhibitory" to vascular tube formation.
Hyaluronic acid (HA; hyaluronan) plays an important role in vascular development by regulating cell proliferation and migration [26] . Using HA as the primary structural component, we have developed hydrogels with high water content that promote cell viability [27] . In a previous study, we engineered a modular culture environment using HA hydrogels to precisely regulate the signaling pathways of ECFC vascular morphogenesis and generate functional microvascular networks. We showed that RGD integrin-binding is required in a dose-dependent manner to initiate vacuole and lumen formation. We then demonstrated that further progression of vascular morphogenesis through branching and sprouting to form complex vascular networks relies on matrixmetalloproteinases (MMPs)-dependent mechanisms [28] . In this report, we extend our previous studies by the incorporation of sequential crosslinking methods to enable spatial control over vascular remodeling. This technique has been previously used to spatially control the spreading [29] and differentiation [30] of human mesenchymal stem cells (hMSCs). It exploits the reactivity of vinyl groups within the HA macromer to create regions that are "permissive" or "inhibitory" to cell-mediated degradation, including vascular remodeling by ex ovo chorioallantoic (CAM) vessels or ECFCs in vitro.
Materials and methods

Human ECFCs
Human umbilical cord blood ECFCs isolated from outgrowth clones, kindly provided by Dr. Merv C. Yoder, Indiana University School of Medicine, were expanded and used for experiments between passages 6 and 8, as previously described [31e33] . Briefly, ECFCs were expanded in flasks coated with type I collagen (Roche Diagnostics, Basel, Switzerland), in endothelial growth medium (EGM; PromoCell Heidelberg, Germany) supplemented with 1 ng/ml VEGF 165 (Pierce, Rockford, IL), and incubated in a humidified incubator at 37 C in an atmosphere containing 5% CO 2 . ECFCs were passaged every three to four days with 0.05% trypsin (Invitrogen, Carlsbad, CA) and characterized for their endothelial cell (EC) surface markers and proliferative potential.
Synthesis of AHA hydrogels
Acrylated HA (AHA) was prepared as previously reported [29] . Briefly, AHA was synthesized using a two-step protocol: (1) the tetrabutylammonium salt of HA (HA-TBA) was produced by reacting sodium hyaluronate (64 kDa; Lifecore Biomedical, Chaska, MN) with the highly acidic ion exchange resin Dowex-100 and neutralized with 0.2 M TBA-OH; (2) acrylic acid (2.5 Eq) was coupled to HA-TBA (1 Eq, repeat unit) in the presence of dimethylaminopyridine (DMAP; 0.075 Eq) and di-tert-butyl dicarbonate (1.5 Eq) in DMSO, followed by dialysis and lyophilization. 1 H NMR was used to assess the modification of HA with acrylate functional groups.
Peptides
From GenScript Corporation (Piscataway, NJ, USA), we obtained the cell adhesive peptide GCGYGRGDSPG (MW: 1025.1 Da; bold italics indicates the RGD integrinbinding domain), MMP-sensitive crosslinker GCRDGPQGYIWGQDRCG (MW: 1754.0 Da; down arrow indicates the site of proteolytic cleavage), all with >95% purity (per manufacturer HPLC analysis).
In vitro vasculogenesis assay
The in vitro vascuologenesis was assessed in AHA hydrogels as previously reported [28] . Briefly, AHA (3 wt%) was dissolved in a sodium phosphate buffered saline (NaPBS buffer: 0.1 M sodium phosphate, 0.3 M total osmolarity, pH 8.0) containing Irgacure 2959 (I2959, Ciba) photoinitiator (final concentration of 0.05 wt%).
The cell adhesive peptides (RGDS; GenScript) were dissolved in NaPBS buffer and added to the AHA solution at final peptide concentrations of 3.7 mM (corresponding to 10% of available acrylate groups within 3 wt% AHA) and were allowed to react for one hour with gentle shaking. Recombinant human VEGF 165 (Pierce, Rockford, IL), bFGF (Invitrogen, Carlsbad, CA), Ang-1 (R&D, Minneapolis, MN), tumor necrosis factor-alpha (TNF-a; R&D) and stromal cell-derived factor-1 (SDF-1; R&D) were added at 50 ng/ml into the AHA-RGDS mixture. Human umbilical cord blood ECFCs were encapsulated in HA hydrogels with densities of 5 Â 10 6 cells/ml. Following the resuspension of cells into this solution, MMP peptide crosslinker (MMP, GenScript) dissolved in NaPBS buffer was added at 4.83 mM (corresponding to the 25% of available acrylate groups within 3 wt% AHA). Immediately after adding the MMP crosslinker, 30 ml of this mixture was pipetted into sterile molds (5 mm diameter, 2 mm height), and was allowed to react for 15 min at room temperature inside the laminar flow hood. The constructs were cultured for up to three days in EGM (PromoCell). Visualization and image acquisition were performed using an inverted light microscope (Olympus IX50, Center Valley, PA) and a confocal microscope (LSM 510 Meta, Carl Zeiss, Inc., Thornwood, NY) at various time intervals along the culture period.
In vitro angiogenesis assay
In vitro angiogenesis into the synthetic HA hydrogel was assessed based on a previously established method using collagen or fibrin gels [34] . Briefly, AHA hydrogels were made as described above with the addition of sphingosine-1-phosphate (S1P, Avanti Polar Lipis, Alabaster, AL) at a concentration of 125 mM.
Human umbilical cord blood ECFCs were seeded on top of the AHA hydrogels and cultured for up to 3 days to allow invasion into the gels. Visualization and image acquisition were performed using an inverted light microscope (Olympus IX50, Center Valley, PA) and a confocal microscope (LSM 510 Meta, Carl Zeiss, Inc., Thornwood, NY) at various time intervals during the culture period.
Spatial patterning of HA hydrogels with UV crosslinking
To spatially pattern the AHA hydrogels, UV light was used to crosslink the free available acrylate groups as previously reported [30] . Stable AHA hydrogels, as described above [28] , were termed uniform "-UV" hydrogels and used as a control, which was expected to support cell-mediated degradation. Selected "-UV" hydrogels were then exposed to 10 mW/cm 2 365 nm ultraviolet light (Omnicure S1000 UV Spot Cure System, Exfo, Ontario, Canada) for 2 min (secondary crosslinking) through glass coverslips to produce uniform "þUV" hydrogels. To obtain patterned AHA hydrogels, 10 k DPI photomasks (CAD/Art Service, Inc., Bandon, OR) with stripes with specific widths as detailed in the text were used in the secondary crosslinking step. To visualize the "þUV" regions of the gels, 5 nM methacrylated rhodamine (MeRho) was mixed into the pre-polymer solution (methacrylate groups react extensively during the secondary radical polymerization, but compared to acrylate groups, crosslinking is too slow during the primary addition reaction) [29] .
Ex ovo angiogenesis assay using CAM model
The CAM assay was prepared ex ovo as previously described [18, 25, 35] . Fertilized white leghorn chicken eggs (B&E Eggs Inc., York Springs, PA) were received at embryonic development day (EDD) 0 and incubated for 3 days at 37 C in a constant humidified incubator with automatic turning (Hova Bator, GQF Manufacturing Company, Savannah, GA). On EDD 3, eggs were rinsed with betadine and 70% ethanol and opened into a 20 Â 100 mm 2 petri dish (BD Falcon) under aseptic conditions.
Then, 10 ml of DMEM-11965 (Invitrogen) containing 200 units/ml of gentamycin and myostatin were added onto the ex ovo culture. The dish was placed inside a larger 25 Â 150 mm petri dish (BD Falcon) containing a thin layer of water for humidification, covered, and incubated at 37 C in a humidified atmosphere of 2% CO 2 . On EDD 8, þ and ÀUV hydrogels were placed onto the CAM membrane and were cultured until EDD 12. The angiogenic response was evaluated by analyzing the convergence of blood vessels toward and inside the graft using a stereomicroscope (Unitron, Commack, NY). The graft and membrane constructs were then harvested, fixed with 3.7% formaldehyde (Sigma), and either stained with fluoresceinconjugated Lens culinaris lectin (1:40, Vector Lab) for confocal imaging (LSM 510 Meta, Carl Zeiss, Inc., Thornwood, NY) or processed for histological analysis.
Histological sectioning and staining
Following fixation of construct explants, samples were dehydrated in graded ethanol (70e100 percent), embedded in paraffin, serially sectioned using a microtome (5 mm), and stained with hematoxylin and eosin (H&E). A minimum of six images were analyzed for each construct.
Viscoelasticity assessment
The oscillatory shear of the elastic modulus (G 0 ) was measured using a constant strain rheometer with steel cone-plate geometry (25 mm in diameter; RFS3; TA Instruments, New Castle, DE), as previously described [31, 32, 36] . Briefly, we performed oscillatory time sweeps on three samples (n ¼ 3) for each hydrogel group at various time intervals along the culture period. The strain was maintained at 20% during the time sweeps by adjusting the stress amplitude at a frequency of 1 Hz. This strain and frequency were chosen because G 0 was roughly frequency-independent within the linear viscoelastic regime. The tests occurred in a humidified chamber at a constant temperature (25 C) in 30-s intervals. The Young's modulus (substrate viscoelasticity) was calculated by E ¼ 2G 0 ð1 þ nÞ. AHA hydrogels are assumed to be incompressible [31, 32, 37] such that their Poisson's ratios ðnÞ approach 0.5 and the relationship becomes E ¼ 3G 0 [36] .
VEGF release and degradation study
At various time points, 1 ml of conditioned media from gels alone and from gels containing cells was collected and replaced with fresh growth media. At the final time point (day 3), the gels were degraded using endogenous 1000 IU/ml hyaluronidase IV (Sigma, St. Louis, MO) for 24 h. The samples of conditioned media were collected (n ¼ 3) and stored at À80 C before being quantified for uronic acid (UA) and VEGF using ELISA kits (Pierce Biotechnology; Rockford, IL) following the manufacturer's instructions and as reported in our previous publications [28, 32, 38] . Results are presented in terms of cumulative release as a function of time.
Swelling ratio
The swelling ratio was gravimetrically measured as previously reported [39] . The pre-dried hydrogel specimens were immersed in distilled water at room temperature. The swollen hydrogels were removed from water at various time points and weighed after wiping off excess water from the surface with a filter paper. The swelling ratio was then calculated according to the following formula:
Where W d is the weight of the dry hydrogels, and W s,t is the weight of the swollen hydrogels at time t. The hydrogels were assumed to reach a state of swelling equilibrium when there was no difference in the swelling ratio between two adjacent time intervals.
Real-time RT-PCR
Two-step RT-PCR was performed for MT1-MMP, MMP-1, MMP-2, HPRT1 and b-ACTIN, and samples were examined in triplicate, analyzed, and graphed (n ¼ 3) as previously described [31, 32] . Briefly, total RNA was extracted using TRIzol (Gibco, Invitrogen Co., Carlsbad, CA) according to the manufacturer's instructions. Total RNA was quantified by an ultraviolet spectrophotometer, and the samples were validated for no DNA contamination. RNA (1 mg per sample) was reverse transcribed using M-MLV (Promega Co., Madison, WI) and oligo (dT) primers (Promega Co.) according to the manufacturer's instructions. TaqMan Universal PCR Master Mix and Gene Expression Assay (Applied Biosystems, Foster City, CA) for MMP-1, MMP-2, MT1-MMP, HPRT1 and b-ACTIN were used according to manufacturer's instructions. The TaqMan PCR step was performed in triplicate with an Applied Biosystems StepOne Real-Time PCR system (Applied Biosystems). The relative expression of MMP1, MMP2, and MT1-MMP was normalized to the amount of HPRT1 or b-ACTIN in the same cDNA by using the standard curve method described by the manufacturer. For each primer set, the comparative CT method (Applied Biosystems) was used to calculate amplification differences between the different samples. The values for experiments (n ¼ 3) were averaged and graphed with standard deviations.
Zymography
The conditioned media from each culture conditions at various time points was collected and analyzed for MMP activity by SDS-PAGE under nonreducing conditions as previously described [25, 40] . Briefly, conditioned media from various time points was loaded on 10% Gelatin and 12% Casein zymography gels (Bio-Rad). Electrophoresis was carried out for 45 min at room temperature. After washing the gels in water, SDS was extracted from acrylamide gels with 2.5% Triton X-100 for 2 Â 30 min. MMP activities were developed in a buffer, pH 8.0, containing 50 mM Tris-HCl, 5 mM CaCl2 and 0.02% NaN3 at 37 C for 24 h and visualized by staining with Coomassie Blue R-250.
Statistical analysis
Expression data of MMPs, UA, and VEGF release were performed on triplicate samples with duplicate readings. Statistical analysis was performed using GraphPad (ii) The hydrogels are then crosslinked by the addition of MMP-sensitive crosslinkers using a primary addition reaction to create a "permissive" ÀUV hydrogels. (iii) The free acrylate groups can be further crosslinked in the presence of photoinitiator and UV light using a secondary radical reaction to create "inhibitory" þUV hydrogels (B) Differential effect of hydrogels degradability on vasculogenesis. (i) Within the ÀUV hydrogels, encapsulated ECFCs undergo complete vasculogenesis to form complex vascular tube networks.
(ii) Within the þUV hydrogels, where kinetic chains are generated through the secondary radical crosslinking, encapsulated ECFCs only form vacuole and lumen (arrowhead), but failed to branch and sprout. ECFCs are stained with Fluorescein-conjugated UEA-I lectin (green) and DAPI (blue). Scale bars are 100 mm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Fig. 2 . Control over ex ovo angiogenesis (A). Uniform ÀUV and þUV AHA hydrogels are grafted onto the CAM membrane at EDD 8 and harvested at EDD 12 (B) LM imaging and (C) confocal analysis of the boxed regions in B shows CAM vessels penetrating into the ÀUV but not into the þUV hydrogels. CAM vessels are stained with Fluorescein-conjugated Lens culinaris lectin (D) H&E analysis further shows that ÀUV hydrogels are degraded (i, and inset), while the þUV hydrogels remain intact (ii, and inset). Scale bars in: B is 20 mm, CeD are 100 mm. H ¼ hydrogels. Dotted white lines indicate the boundaries of the hydrogels. Prism 4.02 (GraphPad Software Inc., La Jolla, CA). T-tests were performed to determine significance using GraphPad Prism 4.02. Significance levels were determined using post-tests, and were set at *p < 0.05, **p < 0.01, and ***p < 0.001. All graphical data were reported.
Results and discussion
Control over in vitro vasculogenesis and ex ovo angiogenesis
In our previous study, we demonstrated that ECFCs undergo vascular morphogenesis within a well-defined synthetic matrix, namely AHA hydrogels modified with RGD and containing MMPcleavable crosslinks [28] . Here, we hypothesized that cellmediated degradation could be exploited to spatially control vascular morphogenesis during vasculogenesis of ECFCs and angiogenesis by ECFCs and ex ovo CAM. Two crosslinking methods were applied sequentially to form the HA hydrogels. In the primary crosslinking method, HA hydrogels are formed from AHA precursors modified with integrin-binding adhesive peptides (via conjugate addition reactions between the thiol groups on RGDS-containing peptides and acrylates along the HA backbone), and then crosslinked with dithiol peptides (thiol groups on each end of the peptide react with the acrylates) via a primary addition reaction generating uniform "-UV" hydrogels (Fig. 1A) . Importantly, only a fraction of the total acrylates is consumed during this first step, leaving a network that is "permissive" to proteolytic degradation. In the presence of a photoinitiator, the remaining acrylates on the HA macromer could be further crosslinked using a secondary radical reaction [30] . In this secondary step, the hydrogels are exposed to UV light, which initiates radical polymerization of the remaining acrylates, resulting in the formation of non-degradable kinetic chains, which are "inhibitory" to cell-mediated degradation (Fig. 1 A) . This technique has been previously used to spatially control the spreading [29] and differentiation [30] of hMSCs.
We first examined if we could inhibit in vitro vasculogenesis of ECFCs. When encapsulated in ÀUV hydrogels, ECFCs were able to undergo vasculogenesis; however, within þUV hydrogels, ECFCs were able to form vacuoles and lumen, but were unable to branch and sprout, arresting the vascular morphogenesis (Fig. 1 B) . We next examined vessel infiltration into þUV and ÀUV AHA hydrogels using ex ovo CAM. We grafted uniform ÀUV and þUV hydrogels onto CAM at EDD 8, at which the mitotic index of EC is optimal ( Fig. 2A) [41] . At EDD 12, we observed extensive vessel invasion into the "permissive" ÀUV hydrogels, but not into the "inhibitory" þUV hydrogels (Fig. 2 B and C) . Histological analysis of the harvested hydrogels constructs further confirmed these observations. The "permissive" ÀUV hydrogels degraded and were penetrated by the CAM vessels (Fig. 2 D, i) , while the "inhibitory" þUV hydrogels remain intact with limited vessel ingrowth (Fig. 2 D, ii) . These two observations showed how cell-mediated degradation can be exploited to provide spatial control over vasculogenesis and angiogenesis assays.
Differential degradation of the ÀUV and þUV AHA hydrogels
To better understand the mechanism by which HA hydrogels alter cellular remodeling in both of the vasculogenesis and angiogenesis assays, we characterized the physical properties of ÀUV and þUV hydrogels. We found that there is no significant difference in the VEGF release profile of ÀUV and þUV hydrogels. Both types of hydrogels released half of the encapsulated VEGF in the first day and retained 20% of the encapsulated VEGF up to day 3 (Fig. 3A) . These observations are in agreement with our previous report that the VEGF release profile is not affected by the hydrogel crosslinking density [32] . However, there is a significant difference in the degradation kinetics of the ÀUV and þUV hydrogels. The ÀUV hydrogels released significantly more uronic acid (UA), the byproduct of HA degradation, compared to the þUV hydrogels (Fig. 3 B) . These results suggested that the ability of the ÀUV hydrogels to "permit" cellular remodeling and the ability of the þUV hydrogels to "inhibit" cellular remodeling in both vasculogenesis and angiogenesis, is attributed to the difference in their degradation kinetics, rather than their release capabilities. Moreover, elastic modulus measurements showed that UV photocrosslinking increases the elastic modulus of HA hydrogels from w200 Pa for ÀUV hydrogels to w800 Pa for þUV hydrogels (Fig. 3  C) . This observation is in agreement with our previous study, which reports that UV crosslinking increases the elastic modulus of HA hydrogels [30] . We also observed that þUV hydrogels maintain a constant swelling ratio of 100%, while ÀUV hydrogels show a steady increase in swelling ratio up to 250% by day 1, at which point they reach a state of swelling equilibrium (Fig. 3 D) . The secondary radical crosslinking created a non-degradable kinetic chain, which also resulted in a higher elastic modulus and a lower swelling rate of the þUV hydrogels compared to the ÀUV hydrogels.
Differential MMP expression in ÀUV and þUV AHA hydrogels
We further characterized the dynamic interactions between ECFCs and the two types of HA hydrogels. We analyzed MMP expression from ECFCs encapsulated in ÀUV and þUV hydrogels over 3 days of culture. We found that during the early culture period up to day 2, ECFCs cultured in þUV hydrogels express significantly higher levels of MMP-1, -2, and -14 compared to the ECFCs cultured in ÀUV hydrogels. In contrast to the MMP expression in ÀUV hydrogels, which increases with culture, the MMP expression in þUV hydrogels initially increases up to day 2 then decreases on day 3 (Fig. 4) . Zymography analysis also detected higher levels of activated MMP-1 and -2 in the conditioned media of ECFCs cultured in þUV hydrogels compared to those in ÀUV hydrogels (Fig. 4 A and B) . These findings are similar to our previous study demonstrating that ECFCs cultured on stiffer matrices express higher levels of MMPs to facilitate matrix degradation and remodeling [31] . However, these high levels of MMP expression in þUV hydrogels did not result in matrix degradation due to the non-degradable bonds created by the kinetic chains (Fig. 3 B  above) . Moreover, MMP expression of ECFCs encapsulated in þUV hydrogels decreases at day 3 after their highest levels at day 2, suggesting the adaptability of ECFCs to their microenvironment. In response to the stiffer and non-degradable matrix, ECFCs secreted high level of MMPs to degrade their surrounding [28, 31] . Nonetheless, faced with the non-degradable kinetic chains within the þUV hydrogels, these high levels of MMP expression did not result in matrix degradation, which led to ECFC adaptation to their surroundings by decreasing the MMP expression at day 3. These results clarified our observations that ECFCs cultured within þUV hydrogels form vacuole and lumen, but are unable to branch and sprout ( Fig. 1 B above) , two cellular events that are tightly regulated by MMPs [23, 24] . Consequently, vascular tube and vessel infiltration were only "permitted" within the ÀUV hydrogels through matrix degradation, yet were "inhibited" within the radicallycrosslinked þUV hydrogels. . Zymography analysis also reveals higher levels of activated MMP-1 (A, bottom) and MMP-2 (B, bottom) in the culture media of ECFCs grown in þUV hydrogels than ÀUV hydrogels. Significance levels are set at *p < 0.05 and **p < 0.01.
Spatial control of ECFC remodeling for in vitro vasculogenesis
A photomask was used to exploit the sequential crosslinking system, to generate ÀUV and þUV regions within the hydrogels. In the þUV region, the remaining free acrylate groups are further crosslinked, creating networks "inhibitory" to cell-mediated degradation and spreading (Fig. 5A) [29] . A variety of photomasks can be used to generate hydrogels with different sizes and patterns of ÀUV and þUV regions (Fig. 5 B) . Within the ÀUV regions, we observed that ECFCs are able to form vacuole and lumen, branches and sprouts, and form vascular tube networks as was previously reported (Fig. 5 B) [28] . The þUV regions are labeled with MeRho, as it reacted rapidly with the free acrylate groups under UV exposure [29, 30] , and are bordered with dotted white lines. Within þUV regions, ECFCs were able to form vacuoles and lumen, but were unable to branch and sprout, arresting the vascular morphogenesis at this stage (Fig. 5 C) . We observed that the ÀUV regions are "permissive" to the complete stages of vascular morphogenesis. ECFCs encapsulated within the "permissive" ÀUV regions are able to form vacuoles and lumen, branch and sprout, and eventually form vascular networks. In contrast, the þUV regions are "inhibitory" to the stages of branching and sprouting, which are considered as MMP-dependent mechanisms. Due to the existence of kinetic chains within the "inhibitory" þUV region, ECFCs can form vacuole and lumen, but are not able to branch and sprout in order to form vascular networks (Fig. 6) . Hence, this photopatterning technique can be used to spatially control vascular tube formation of ECFCs during vasculogenesis in hydrogels. The ability to spatially control vascular networks within synthetic biomaterials can benefit the generation of more complex and organized vasculatures, which in turn can improve the survival and functionality of tissueengineered organs [14] .
Spatial control over in vitro angiogenesis
To mimic the process of angiogenesis, Davis and colleagues developed an in vitro angiogenesis assay using collagen gels [5, 34] . In response to SDF-1a and S1P, a confluent monolayer of endothelial cells (ECs) are shown to invade and sprout into the collagen gels underneath in a way that mimics the appearance of tip cells from pre-existing blood vessels [34] . Here, we hypothesized that HA hydrogels could be used as an in vitro angiogenesis assay, and as such, provide opportunities to elucidate the role of matrix remodeling during angiogenesis in synthetic biomaterials. After 3 days in culture, a confluent monolayer of ECFCs invaded and sprouted into the 3D hydrogels (Fig. 7A) . Since ECFCs invasion and sprouting requires matrix degradation, which mainly relies on MMP activities [31] , we further examined whether photopatterned hydrogels could be used to direct angiogenesis by ECFCs. Using a 100 mm-wide stripe pattern, ECFCs invasion and sprouting was permitted within ÀUV regions and inhibited within the þUV region (Fig. 7 B) . Confluent monolayers of ECFCs began to sprout and invade into the ÀUV region (Fig. 7 B, i) , and further branched along the ÀUV region (Fig. 7 B , ii). ECFCs were not able to invade and . HA hydrogels for spatially controlled vascular Morphogenesis. Within the ÀUV region, vascuologenesis is "permitted." encapsulated ECFCs cultured within the ÀUV region are able to form vacuoles and lumens, followed by branching and sprouting, and eventually form complex vascular networks. Photocrosslinking introduces non-degradable kinetic chains within the þUV region, thus inhibiting branching, sprouting, and the formation of complex vascular networks. Fig. 7 . Spatial control over in vitro angiogenesis. ECFCs are seeded on top of a uniform ÀUV (A) and 100 mm stripe photopatterned (B) HA hydrogels for angiogenesis assay. After 3 days in culture, ECFCs invade and sprout into the 3D hydrogels (A) When photopatterned HA hydrogels are used, invasion and sprouting are observed only within the ÀUV regions and not within the inhibitory þUV region (B). Confluent monolayer of ECFCs sprouts and invades the ÀUV region (i), and further branches along the ÀUV regions (ii). The þUV regions are labeled using MeRho (red), ECFCs are stained with Fluorescein-conjugated UEA-I lectin (green) and DAPI (blue). Scale bars are 100 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) sprout into the þUV region due to the non-degradable kinetic chains formed by the secondary radical crosslinking. Thus, this photopatterning technique based on cell-mediated degradation can be further used to direct ECFCs during angiogenic invasion and sprouting.
Conclusions
Collectively, we have shown how synthetic and tunable HA hydrogels can be used as vasculogenesis and angiogenesis assays, which provide unique opportunities to elucidate the role of matrix remodeling throughout these processes. Furthermore, we demonstrated how manipulating the degradability of synthetic biomaterials can be used to provide spatial degradation cues, which are either "permissive" or "inhibitory" to vascular tube formation. With high spatial precision, we can create ÀUV regions, which are "permissive" to vascular tube formation and þUV regions, which are "inhibitory" to vascular tube formation. Our understanding and ability to control degradation cues that "permit" or "inhibit" vasculogenesis and angiogenesis in synthetic biomaterials can be valuable for the basic study of vascular biology and for the application of improving vascular organization in tissue engineering.
